CTLA4 and breast cancer: In addition, differential responses were observed following 24-hour incubation of MDA-MB-231 and MCF-7 BC cells with peripheral blood mononuclear cells (PBMCs) alone or in combination with CTLA-4 or PD-1 inhibitors.